MRGPRX2 ANTAGONISTS FOR THE TREATMENT OF INFLAMMATORY DISORDERS
The present disclosure is directed to use of MrgprX2 antagonists in the treatment of inflammatory disorders, e.g., inflammatory disorders of the skin. This invention is also directed to pharmaceutical compositions comprising a MrgprX2 antagonist and a pharmaceutically or orally acceptable carrier fo...
Gespeichert in:
| Hauptverfasser: | , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; fre |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | GLEAVE, LAURA URSINYOVA, NINA CONNELLY YAU, WEI TSUNG CEVIKBAS, FERDA CAIN, RICKY JARVIS, ASHLEY |
| description | The present disclosure is directed to use of MrgprX2 antagonists in the treatment of inflammatory disorders, e.g., inflammatory disorders of the skin. This invention is also directed to pharmaceutical compositions comprising a MrgprX2 antagonist and a pharmaceutically or orally acceptable carrier for administration.
La présente invention concerne l'utilisation d'antagonistes de MrgprX2 dans le traitement de troubles inflammatoires, par exemple, de troubles inflammatoires de la peau. La présente invention concerne également des compositions pharmaceutiques comprenant un antagoniste de MrgprX2 et un support pharmaceutiquement ou oralement acceptable pour l'administration. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_CA3159766A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CA3159766A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_CA3159766A13</originalsourceid><addsrcrecordid>eNrjZLD3DXIPCIowUnD0C3F09_fzDA4JVnDzD1II8XBVCAlydQzxdfULUfB3U_D0c_Nx9PV1DPEPilRw8Qz2D3JxDQrmYWBNS8wpTuWF0twMCm6uIc4euqkF-fGpxQWJyal5qSXxzo7GhqaW5mZmjobGRCgBAFQJKkY</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>MRGPRX2 ANTAGONISTS FOR THE TREATMENT OF INFLAMMATORY DISORDERS</title><source>esp@cenet</source><creator>GLEAVE, LAURA ; URSINYOVA, NINA CONNELLY ; YAU, WEI TSUNG ; CEVIKBAS, FERDA ; CAIN, RICKY ; JARVIS, ASHLEY</creator><creatorcontrib>GLEAVE, LAURA ; URSINYOVA, NINA CONNELLY ; YAU, WEI TSUNG ; CEVIKBAS, FERDA ; CAIN, RICKY ; JARVIS, ASHLEY</creatorcontrib><description>The present disclosure is directed to use of MrgprX2 antagonists in the treatment of inflammatory disorders, e.g., inflammatory disorders of the skin. This invention is also directed to pharmaceutical compositions comprising a MrgprX2 antagonist and a pharmaceutically or orally acceptable carrier for administration.
La présente invention concerne l'utilisation d'antagonistes de MrgprX2 dans le traitement de troubles inflammatoires, par exemple, de troubles inflammatoires de la peau. La présente invention concerne également des compositions pharmaceutiques comprenant un antagoniste de MrgprX2 et un support pharmaceutiquement ou oralement acceptable pour l'administration.</description><language>eng ; fre</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2021</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20210514&DB=EPODOC&CC=CA&NR=3159766A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25543,76293</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20210514&DB=EPODOC&CC=CA&NR=3159766A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>GLEAVE, LAURA</creatorcontrib><creatorcontrib>URSINYOVA, NINA CONNELLY</creatorcontrib><creatorcontrib>YAU, WEI TSUNG</creatorcontrib><creatorcontrib>CEVIKBAS, FERDA</creatorcontrib><creatorcontrib>CAIN, RICKY</creatorcontrib><creatorcontrib>JARVIS, ASHLEY</creatorcontrib><title>MRGPRX2 ANTAGONISTS FOR THE TREATMENT OF INFLAMMATORY DISORDERS</title><description>The present disclosure is directed to use of MrgprX2 antagonists in the treatment of inflammatory disorders, e.g., inflammatory disorders of the skin. This invention is also directed to pharmaceutical compositions comprising a MrgprX2 antagonist and a pharmaceutically or orally acceptable carrier for administration.
La présente invention concerne l'utilisation d'antagonistes de MrgprX2 dans le traitement de troubles inflammatoires, par exemple, de troubles inflammatoires de la peau. La présente invention concerne également des compositions pharmaceutiques comprenant un antagoniste de MrgprX2 et un support pharmaceutiquement ou oralement acceptable pour l'administration.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2021</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZLD3DXIPCIowUnD0C3F09_fzDA4JVnDzD1II8XBVCAlydQzxdfULUfB3U_D0c_Nx9PV1DPEPilRw8Qz2D3JxDQrmYWBNS8wpTuWF0twMCm6uIc4euqkF-fGpxQWJyal5qSXxzo7GhqaW5mZmjobGRCgBAFQJKkY</recordid><startdate>20210514</startdate><enddate>20210514</enddate><creator>GLEAVE, LAURA</creator><creator>URSINYOVA, NINA CONNELLY</creator><creator>YAU, WEI TSUNG</creator><creator>CEVIKBAS, FERDA</creator><creator>CAIN, RICKY</creator><creator>JARVIS, ASHLEY</creator><scope>EVB</scope></search><sort><creationdate>20210514</creationdate><title>MRGPRX2 ANTAGONISTS FOR THE TREATMENT OF INFLAMMATORY DISORDERS</title><author>GLEAVE, LAURA ; URSINYOVA, NINA CONNELLY ; YAU, WEI TSUNG ; CEVIKBAS, FERDA ; CAIN, RICKY ; JARVIS, ASHLEY</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_CA3159766A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2021</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>GLEAVE, LAURA</creatorcontrib><creatorcontrib>URSINYOVA, NINA CONNELLY</creatorcontrib><creatorcontrib>YAU, WEI TSUNG</creatorcontrib><creatorcontrib>CEVIKBAS, FERDA</creatorcontrib><creatorcontrib>CAIN, RICKY</creatorcontrib><creatorcontrib>JARVIS, ASHLEY</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>GLEAVE, LAURA</au><au>URSINYOVA, NINA CONNELLY</au><au>YAU, WEI TSUNG</au><au>CEVIKBAS, FERDA</au><au>CAIN, RICKY</au><au>JARVIS, ASHLEY</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>MRGPRX2 ANTAGONISTS FOR THE TREATMENT OF INFLAMMATORY DISORDERS</title><date>2021-05-14</date><risdate>2021</risdate><abstract>The present disclosure is directed to use of MrgprX2 antagonists in the treatment of inflammatory disorders, e.g., inflammatory disorders of the skin. This invention is also directed to pharmaceutical compositions comprising a MrgprX2 antagonist and a pharmaceutically or orally acceptable carrier for administration.
La présente invention concerne l'utilisation d'antagonistes de MrgprX2 dans le traitement de troubles inflammatoires, par exemple, de troubles inflammatoires de la peau. La présente invention concerne également des compositions pharmaceutiques comprenant un antagoniste de MrgprX2 et un support pharmaceutiquement ou oralement acceptable pour l'administration.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; fre |
| recordid | cdi_epo_espacenet_CA3159766A1 |
| source | esp@cenet |
| subjects | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | MRGPRX2 ANTAGONISTS FOR THE TREATMENT OF INFLAMMATORY DISORDERS |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-24T00%3A50%3A42IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=GLEAVE,%20LAURA&rft.date=2021-05-14&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ECA3159766A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |